Oral squamous cell cancer: Early detection and the role of alcohol and smoking

Head and Neck Oncology

Volumn 3, Issue 1, 2011, Pages

  Zygogianni, Anna G ^a   Kyrgias, George ^b   Karakitsos, Petros ^c   Psyrri, Amanta ^d   Kouvaris, John ^a   Kelekis, Nikolaos ^a   Kouloulias, Vassilis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c General National Hospital   (Greece)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALCOHOL DEHYDROGENASE; ALPHA SMOOTH MUSCLE ACTIN; AMINOLEVULINIC ACID; CARCINOGEN; CLAUDIN; CYCLOOXYGENASE 2; CYTOCHROME P450 2E1; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTATHIONE TRANSFERASE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; KI 67 ANTIGEN; LIPOCORTIN 1; OCCLUDIN; OSTEOCLAST DIFFERENTIATION FACTOR; PHOTOFRIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN BCL 2; PROTEIN ERCC6; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR B1; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; XRCC4 PROTEIN;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; CANCER DIAGNOSIS; CANCER GENETICS; CANCER RISK; CIGARETTE SMOKING; CYTODIAGNOSIS; DNA DETERMINATION; DRINKING BEHAVIOR; ENVIRONMENTAL EXPOSURE; FAMILIAL CANCER; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; IMAGE CYTOMETRY; MOUTH CARCINOMA; NONHUMAN; PAPILLOMAVIRUS INFECTION; PHOTODYNAMICS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; CYTOLOGY; EARLY DIAGNOSIS; METHODOLOGY; MOUTH TUMOR; SMOKING;

ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CYTOLOGICAL TECHNIQUES; EARLY DETECTION OF CANCER; HUMANS; MOUTH NEOPLASMS; SMOKING;

EID: 78650873093     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-3-2     Document Type: Review

References (94)

1. Tongue and tonsil carcinoma: increasing trends in the US population ages 20-44 years. CH Shiboski BL Schmidt RC Jordan, Cancer 2005 103 9 1843 1849 10.1002/cncr.20998 15772957
2. Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. CD Llewellyn K Linklater J Bell NW Johnson KA Warnakulasuriya, Oral Oncol 2003 39 2 106 114 10.1016/S1368-8375(02)00026-X 12509963
3. Survival in patients under 45 years with squamous cell carcinoma of the oral tongue. S Manuel SK Raghavan M Pandey P Sebastian, Int J Oral Maxillofac Surg 2003 32 2 167 173 10.1054/ijom.2002.0271 12729777
4. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach. AL Carvalho J Magrin LP Kowalski, Oral Dis 2003 9 3 109 111 10.1034/j.1601-0825.2003.01750.x 12945591
5. Molecular therapy of head and neck cancer. H Modjtahedi, Cancer Metastasis Rev 2005 24 1 129 146 10.1007/s10555-005-5052-4 15785877
6. Tumor thickness predicts cervical nodal metastases and survival in early oral tongue cancer. P O-charoenrat G Pillai S Patel C Ficher D Archer S Eccles P Phys-Evans, Oral Oncol 2003 39 386 390 10.1016/S1368-8375(02)00142-2 12676259
7. Early stage carcinoma of oral tongue: prognostic factors for local control and survival. N Al-Rajhi Y Khafaga J El-Husseiny M Saleem W Mourad A Al-Otieschan A Al-Amro, Oral Oncol 2000 36 508 514 10.1016/S1368-8375(00)00042-7 11036243
8. Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer. KCB Ribeiro LP Kowalski MRDO Latorre, Arch Otolaryngol Head Neck Surg 2003 129 219 228 12578453
9. The role of diagnostic delays in the prognosis of oral cancer: a review of the literature. P Allison D Locker JS Feine, Oral Oncol 1998 34 161 170 10.1016/S1368-8375(97)00071-7 9692049 (Pubitemid 28267166)
10. CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early- and late-stage oral squamous cell carcinoma - a pilot study. F Fialka RM Gruber R Hitt L Opitz E Brunner H Schliephake FJ Kramer, Oral Oncol 2008 44 10 941 948 10.1016/j.oraloncology.2007.10.011 18234543
11. Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas. WF Chiang SY Liu CY Yen CN Lin YC Chen SC Lin KW Chang, Oral Oncol 2008 44 3 270 276 10.1016/j.oraloncology.2007.02.008 17468034
12. Glutathione S-transferase polymorphisms and oral cancer: a case-control study in Rio de Janeiro, Brazil. A Hatagima EC Costa CF Marques RJ Koifman P Boffetta S Koifman, Oral Oncol 2008 44 2 200 207 10.1016/j.oraloncology.2007.02. 001 17418613
13. Genetic association of cytokine DNA polymorphisms with head and neck cancer. Z Serefoglou C Yapijakis E Nkenke E Vairaktaris, Oral Oncol 2008 44 12 1093 1099 10.1016/j.oraloncology.2008.02.012 18486534
14. Association of TNF-alpha and TNFR1 promoters and 30 UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. R Gupta SC Sharma SN Das, Oral Oncol 2008 44 5 455 463 10.1016/j.oraloncology.2007.06.003 18206417
15. Polymorphisms of COX-2 -765 G > C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population. YC Lin HI Huang LH Wang CC Tsai O Lung CY Dai ML Yu CK Ho CH Chen, Oral Oncol 2008 44 8 798 804 10.1016/j.oraloncology.2007.10.006 18234542
16. A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. CF Chiu MH Tsai HC Tseng CL Wang FJ Tsai CC Lin DT Bau, Oral Oncol 2008 44 6 582 586 10.1016/j.oraloncology. 2007.07.006 17933579
17. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. CF Chiu MH Tsai HC Tseng CL Wang CH Wang CN Wu CC Lin DT Bau, Oral Oncol 2008 44 9 898 902 10.1016/j.oraloncology.2007.11.007 18164646
18. Oral cancer and genetic polymorphism of DNA double strand break gene Ku70 in Taiwan. Da-Tian Bau Hsien-Chang Tseng Chung-Hsing Wang Chang-Fang Chiu Chun-Hung Hua Cheng-Nan Wu Liang Shiu-Yun Wang Cheng-Li Tsai Chia-Wen Tsai Ming-Hsui, Oral Oncol 2008 44 1047 1051 10.1016/j.oraloncology.2008.02.008 18487076
19. Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma. CM Coutinho Camillo SV Lourenco IN Nishimoto LP Kowalski FA Soares, Histopathology 2010 57 304 316 10.1111/j.1365-2559.2010.03621.x 20716171
20. Synergistic effect of stromelysin-1(matrix metalloproteinase-3)promoter (-117 5 A- > 6A)polymorphism in oral submucous fibrosis and head and neck lesions. AK Chaudhary M Singh AC Bharti M Singh S Shukla AK Singh R Mehrotra, BMC CANCER 2010 10 369 10.1186/1471-2407-10-369 20630073
21. Tight junction proteins and cancer-associated fibroblasts in ameloblastoma, ameloblastic carcinoma and mobile tongue cancer. Bello O Ibrahim, Acta Univ Oul 2010 1040
22. Carcinogenicity of alcoholic beverages. R Baan K Straif Y Grosse B Secretan F EI Ghissassi V Bouvard A Altieri V Cogliano, Lancet Oncol 2007 8 292 293 10.1016/S1470-2045(07)70099-2 17431955
23. Food, nutrition, physical Activity, and the prevention of cancer: a global perspective. World Cancer Research Fund and American Institute for Cancer Research, AICR, Washington DC 2007
24. Molecular mechanisms of alcohol-mediated carcinogenesis. HK Seitz F Stickel, Nat Rev Cancer 2007 7 599 612 10.1038/nrc2191 17646865
25. Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma. T Asakage A Yokoyama T Haneda M Yamazaki M Muto T Yokoyama H Kato H Igaki T Tsujinaka Y Kumanagai M Yokoyama T Omori H Watanable, Carcinogenesis 2007 28 865 874 10.1093/carcin/bgl206 17071628
26. Gene-gene and gene-environment interactions between alcohol drinking habit and polymorphisms in alcohol-metabolizing enzyme genes and the risk of head and neck cancer in Japan. A Hiraki K Matsuo K Wakai T Suzuki Y Hasegawa K Tajima, Cancer Sci 2007 98 1087 1091 10.1111/j.1349-7006.2007.00505.x 17489985
27. Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. M Hashibe P Boffetta D Zaridze O Shangina N Szeszenia-Dabrowska D Mates V Janout E Fabianova V Bencko N Moullan A Chabrier R Hung J Hall F Canzian P Brennan, Cancer Epidemiol Biomarkers Prev 2006 15 696 703 10.1158/1055-9965.EPI-05-0710 16614111
28. Multiple ADH genes are associated with upper aerodigestive cancers. M Hashibe JD McKay MP Curado LC Oliviera S Koifman R Koifman D Zaridze O Shangina V Wunsch-Filno EJ Neto JE Levi E Matos P Lagiou A Lagiou S Benhamou C Bouchardy NS Dabrouska A Menezes Marinel Mor Dall'Agnol F Merletti L Richiardi L Fernandez J Lence R Talamini L Barzan D Mates IN Mates K Kjaerheim GJ Macfarlane TV Macfarlane,, et al. Nat Genet 2008 40 707 709 10.1038/ng.151 18500343
29. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. A Yokoyama T Omori, Alcohol 2005 35 175 185 10.1016/j.alcohol.2005.04.003 16054979
30. Laryngeal cancer risk in Caucasians is associated with alcohol and tobacco consumption but not modified by genetic polymorphisms in class I alcohol dehydrogenases ADH1B and ADH1C, and glutathione-S-transferases GSTM1 and GSTT1. A Risch H Ramroth V Raedts N Rajaee-Behbahani P Schmezer H Bartsch H Becher A Dietz, Pharmacogenetics 2003 13 225 230 10.1097/00008571-200304000-00007 12668919
31. The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. ES Peters MD McClean M Liu EA Eisen N Mueller KT Kelsey, Cancer Epidemiol Biomarkers Prev 2005 14 476 482 10.1158/1055-9965.EPI-04-0431 15734975
32. Alcohol dehydrogenase 3 and risk of squamous cell carcinomas of the head and neck. D Wang JM Ritchie EM Smith Z Zhang LP Turek TH Haugen, Cancer Epidemiol Biomarkers Prev 2005 14 626 632 10.1158/1055-9965.EPI-04-0343 15767341
33. Interaction between a single nucleotide polymorphism in the alcohol dehydrogenase 3 gene, alcohol consumption and oral cancer risk. AI Zavras T Wu G Laskaris YF Wang V Cartsos J Segar D Lefantzis K Joshipura CW Douglas SR Diehl, Int J Cancer 2002 97 526 530 10.1002/ijc.1642 11802217
34. Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. C Bouchardy A Hirvonen C Coutelle PJ Ward P Dayer S Benhamou, Int J Cancer 2000 87 734 740 10.1002/1097-0215(20000901)87:5<734::AID-IJC173.0.CO;2-E 10925369
35. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. MW Yu A Gladek-Yarborough S Chiamprasert RM Santella YF Liaw CJ Chen, Gastroenterology 1995 109 1266 1273 10.1016/0016-5085(95)90587-1 7557094
36. One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study. T Suzuki K Matsuo Y Hasegawa A Hiraki K Wakai K Hirose T Saito S Sato R Ueda K Tajima, Cancer Sci 2007 98 1439 1446 10.1111/j.1349-7006.2007.00533.x 17596206 (Pubitemid 47241768)
37. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. I Weisberg P Tran B Christensen S Sibani R Rozen, Mol Genet Metab 1998 64 169 172 10.1006/mgme.1998.2714 9719624
38. Association between methylenetetrahydrofolate reductase polymorphisms, alcohol intake and oropharyngolaryngeal carcinoma in northern Italy. P Capaccio F Ottaviani V Cuccarini S Cenzuales BM Cesana L Pignataro, J Laryngol Otol 2005 119 371 376 15949101
39. Changes in smoking status among substance abusers: baseline characteristics and abstinence from alcohol and drugs at 12-month follow-up. CS Kohn JY Tsoh CM Weisner, Drug Alcohol Depend 2003 69 61 71 10.1016/S0376- 8716(02)00256-9 12536067
40. Nicotine dependence and withdrawal in alcoholic and nonalcoholic ever-smokers. JL Marks EM Hill CS Pomerleau SA Mudd FC Blow, J Subst Abuse Treat 1997 14 521 527 10.1016/S0740-5472(97)00049-4 9437623
41. Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. A Znaor P Brennan V Gajalakshmi A Mathew V Shanta C Varghese P Boffetta, Int J Cancer 2003 105 681 686 10.1002/ijc.11114 12740918
42. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. R Talamini C Bosetti C La Vecchia L Dal Maso F Levi E Bidoli E Negri C Pasche S Vaccarella L Barzan S Franceschi, Cancer Causes Control 2002 13 957 964 10.1023/A:1021944123914 12588092
43. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). KA Do MM Johnson DA Doherty JJ Lee XF Wu Q Dong WK Hong FR Khuri KK Fu MR Spitz, Cancer Causes Control 2003 14 131 138 10.1023/A:1023060315781 12749718
44. Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract. M Morita H Saeki M Mori H Kuwano K Sugimachi, Surgery 2002 131 1 S6 10.1067/msy.2002.119287 11821780
45. The relation of alcohol consumption and cigarette smoking to the multiple occurrence of esophageal dysplasia and squamous cell carcinoma. M Miyazaki S Ohno M Futatsugi H Saeki T Ohga M Watanabe, Surgery 2002 131 7 13 10.1067/msy.2002.119288 (Pubitemid 34118610)
46. Antibodies against 5-hydroxymethyl-2'-deoxyuridine are associated with lifestyle factors and GSTM1 genotype: a report from the Malmo Diet and Cancer cohort. P Wallstrom K Frenkel E Wirfalt B Gulberg J Karkoszka J Seidegard L Janzon G Berglund, Cancer Epidemiol Biomarkers Prev 2003 12 444 451 12750240
47. Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: relation to single strand breaks of DNA. PH Villard EM Seree JL Re M De Meo Y Barra L Attolini G Dumenil J Catalin A Durand Lacarelle, Toxicol Appl Pharmacol 1998 148 195 204 10.1006/taap.1997.8332 9473526
48. Cytochrome P-4502E1: its physiological and pathological role. CS Lieber, Physiol Rev 1997 77 517 544 9114822
49. Differential induction of CYP1A1 and CYP1B1 by benzo[a]pyrene in oral squamous cell carcinoma cell lines and by tobacco smoking in oral mucosa. AC Chi K Appleton JB Henriod JW Krayer NM Marlow D Bandyopadhyay RC Sigmon Kurtz, Oral Oncol 2009 45 980 5 10.1016/j.oraloncology.2009.05.562 19576839
50. Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. S Miksys C Lerman PG Shields DC Mash RF Tyndale, Neuropharmacology 2003 45 122 132 10.1016/S0028-3908(03)00136-9 12814665
51. Loss of expression of DNA repair enzyme MGMT in oral leukoplakia and early oral squamous cell carcinoma. A prognostic tool? M Rodriquez A Acha M Ruesga C Rodriquez J Rivera J Aguirre, Cancer Letters 2007 245 263 268 10.1016/j.canlet.2006.01.015 16517062
52. Mechanisms of alcohol-nicotine interactions: alcoholics versus smokers. T Narahashi B Soderpalm M Ericson P Olausson JA Engel X Zhang A Nordberg W Marszalec GL Aistrup LG Schmidt U Kalouti A Smolka L Hedlund, Alcohol Clin Exp Res ISBRA 2001 25 Suppl 5 152 156
53. Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. B Soderpalm M Ericson P Olausson O Blomqvist JA Engel, Behav Brain Res 2000 113 85 96 10.1016/S0166-4328(00)00203-5 10942035
54. Potential regulation of nicotine and ethanol actions by alpha4-containing nicotinic receptors. T Tritto RJ Marley D Bastidas JA Stitzel AC Collins, Alcohol 2001 24 69 78 10.1016/S0741-8329(01)00135-5 11522425
55. Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. Z Xu FJ Seidler MM Cousins W Slikker Jr TA Slotkin, Brain Res 2002 951 280 292 10.1016/S0006-8993(02)03174-8 12270507
56. Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. J Pintos MJ Black N Sadeghi P Ghadirian AG Zeitouni RP Viscidi R Herrero EL Contlee Fand Franco, Oral Oncol 2008 44 3 242 250 10.1016/j.oraloncology.2007.02.005 17467327
57. HPV16 transmission between a couple with HPV-related head and neck cancer. R Haddad C Crum Z Chen J Krane M Posner Y Li R Burk, Oral Oncol 2008 44 8 812 815 10.1016/j.oraloncology.2007.09.004 18061523
58. The sensitivity and specificity of the OralCDx technique:evaluation of 103 cases. C Scheifele AM Schmidt-Westhausen T Dietrich PA Reichart, Oral Oncol 2004 40 824 828 10.1016/j.oraloncology.2004.02.004 15288838
59. DNA content as a prognostic marker in patients with oral leukoplakia. J Sudbo W Kildal B Risberg HS Koppang HE Danielsen A Reith, N Engl J Med 2001 344 1270 1278 10.1056/NEJM200104263441702 11320386
60. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. AL Carvalho C Jeronimo MM Kim R Henrique Z Zhang M Hoque S Chang M Brait C Nayak WW Jiang Q Claybourne Y Tokumaru J Lee D Goldenberg E Garrett-Mayer S Goodman C Moon W Koch W Westra D Sidransky J Califano, Clin Cancer Res 2008 14 97 107 10.1158/1078-0432.CCR-07-0722 18172258
61. Cytologic and DNAcytometric very early diagnosis of oral cancer. D Maraki J Becker A Boecking, J Oral Pathol Med 2004 33 398 404 10.1111/j.1600-0714. 2004.0235.x 15250831
62. Endogenous porphyrin fluorescence in tumors. DM Harris J Werkhaven, Lasers Surg Med 1987 7 467 472 10.1002/lsm.1900070605 3123828
63. Fluorescence spectroscopy combined with 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in detecting oral premalignancy. A Sharwani W Jerjes V Salih AJ MacRobert M El-Maaytah HSM Khalil C Hopper, J Photochem Photobiol B 2006 83 27 33 10.1016/j.jphotobiol.2005.11.007 16406802
64. Topical application of photofrin for photodynamic diagnosis of oral neoplasms. CJ Chang P Wilder-Smith, Plast ReconstrSurg 2005 115 1877 1886 10.1097/01.PRS.0000164684.69899.7B (Pubitemid 40770496)
65. Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. NS Soukos MR Hamblin S Keel RL Fabian TF Deutsch T Hasan, Cancer Res 2001 61 4490 4496 11389080
66. Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer. A Sharwani W Jerjes C Hopper MP Lewis M El-Maaytah HSM Khalil AJ MacRobert T Upile V Salih, Arch Oral Biol 2006 51 1104 1111 10.1016/j.archoralbio.2006.05.012 16889746
67. A quantitative colocalization analysis of large unspliced tenascin-C(L) and laminin-5/2-chain in basement membranes of oral squamous cell carcinoma by confocal laser scanning microscopy. M Franz T Hansen L Borsi C Geier P Hyckel P Schleier P Richter A Altendorf-Hofmann H Kosmehl A Berndt, J Oral Pathol Med 2007 36 6 11 10.1111/j.1600-0714.2006.00492.x 17181735
68. Laminin-5 immunocytochemistry:a new tool for identifying dysplastic cells in oral brush biopsies. O Driemel R Dahse SG Hakim T Tsioutsias H Pistner TE Reichert H Kosmehl, Cytopathology 2007 18 348 355 10.1111/j.1365-2303.2006. 00401.x 18031447
69. High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsies. O Driemel R Dahse A Berndt H Pistner SG Hakim L Zardi TE Reichert H Kosmehl, Clin Oral Investig 2007 11 93 99 10.1007/s00784-006-0086-8 17111122
70. Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. C Chen E Mendez J Houck W Fan P Lohavanichbutr D Doody B Yueh N Futran M Upton G Farwell S Schwartz LP Zhao, Cancer Epidemiol Biomarkers Prev 2008 17 2152 2162 10.1158/1055-9965.EPI-07-2893 18669583
71. Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma. WY Chuang CJ Yeh YC Wu YK Chao YH Liu CK Tseng HP Liu C Hsueh, Histol Histopathol 2009 24 1021 1027 19554509
72. Serine protease inhibitor (SERPIN) B1 promotes oral cancer cell motility and is overexpressed in invasive oral squamous cell carcinoma. MY Tseng SY Liu HR Chen YJ Wu CC Chiu PT Chan WF Chiang YC Liu CY Lu YS Jou JYF Chen, Oral Oncol 2009 45 771 776 10.1016/j.oraloncology.2008.11.013 19213596
73. Pin1 overexpression is associated with poor differentiation and survival in oral squamous cell carcinoma. KW Leung CH Tsai M Hsiao CJ Tseng LP Ger KH Lee PJ Lu, Oncol Rep 2009 21 1097 1104 19288014
74. Expression of hypoxia-inducible factor-1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. PY Lin CH Yu JT Wang HH Chen SJ Cheng MYP Kuo CP Chiang, J Oral Pathol Med 2008 37 18 25 10.1111/j.1600-0714.2007.00571.x 18154573
75. Hypoxia inducible factor- expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma. X Liang D Yang J Hu X Hao J Gao Z Mao, Anticancer Res 2008 28 1659 1666 18630523
76. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. T Ishikawa K Nakashiro SK Klosek H Goda S Hara D Uchida H Hamakawa, Oncol Rep 2009 21 707 712 19212630
77. Hypoxiainducible factor 1 in oral squamous cell carcinoma and its relation to prognosis. M Uehara K Sano H Ikeda M Nonaka I Asahina, Oral Oncol 2009 45 241 246 10.1016/j.oraloncology.2008.05.007 18675581
78. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma. CY Lin YM Jeng HY Chou HC Hsu RH Yuan CP Chiang MYP Kuo, J Surg Oncol 2008 97 544 550 10.1002/jso.20992 18297688
79. Down-regulation of plasma membranous Annexin A1 protein expression in premalignant and malignant lesions of the oral cavity: correlation with epithelial differentiation. H Nomura K Uzawa Y Yamano K Fusimi D Nakashima Y Kouzu A Kasamatsu K Ogawara M Shiiba H Bukawa, J Cancer Res Clin Oncol 2009 135 943 949 10.1007/s00432-008-0530-z 19101730
80. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma. L Zhang X Yang LP Zhong XJ Zhou HY Pan KJ Wei J Li WT Chen ZY Zhang, J Oral Pathol Med 2009 38 362 370 10.1111/j.1600-0714.2008.00678.x 18673418
81. Immunohistochemical expression of RANKL, RANK, and OPG in human oral squamous cell carcinoma. FH Chuang SS Hsue CW Wu YK Chen, J Oral Pathol Med 2009 38 753 758 10.1111/j.1600-0714.2009.00793.x 19566744
82. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and highgrade oral squamous cell carcinoma. SH Chiou CC Yu CY Huang SC Lin CJ Liu TH Tsai SH Chou CS Chien HH Ku JF Lo, Clin Cancer Res 2008 14 4085 4095 10.1158/1078-0432.CCR-07-4404 18593985
83. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. YJ Chen JT Chang CT Liao HM Wang TC Yen CC Chiu YC Lu HF Li AJ Cheng, Cancer Sci 2008 99 1507 1514 10.1111/j.1349-7006.2008.00863.x 18754860
84. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients. CH Chen YS Lin CC Lin YH Yang YP Ho CC Tsai, J Oral Pathol Med 2004 33 589 594 10.1111/j.1600-0714.2004.00209.x 15482324
85. Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC). JY Chen YL Chang YC Yu CC Chao HW Kao CT Wu WC Lin JY Ko YS Jou, Carcinogenesis 2004 25 269 276 10.1093/carcin/bgh006 14604896
86. Upregulation of matrix metalloproteinase-1 (MMP-1) expression in oral carcinomas of betel quid (BQ) users: roles of BQ ingredients in the acceleration of tumour cell motility through MMP-1. CH Lee SY Liu MH Lin WF Chiang TC Chen WT Huang DS Chou CT Chiu YC Liu, Arch OralBiol 2008 53 810 818 10.1016/j.archoralbio.2008.05.004
87. Upregulation of matrix metalloproteinase-8 by betel quid extract and arecoline and its role in 2D motility. SY Liu YC Liu WT Huang GC Huang TC Chen MH Lin, Oral Oncol 2007 43 1026 1033 10.1016/j.oraloncology.2006.11.018 17306610
88. Src family kinases mediate betel quid-induced oral cancer cell motility and could be a biomarker for early invasion in oral squamous cell carcinoma. JY Chen CC Hung KL Huang YT Chen SY Liu WF Chiang HR Chen CY Yen YJ Wu JY Ko YS Jou, Neoplasia 2008 10 1393 1401 19048118
89. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. SC Lin CJ Liu WI Yeh MT Lui KW Chang CS Chang, Cancer Lett 2006 243 47 54 10.1016/j.canlet.2005.11.019 16387424
90. Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers. HS Liu HH Lu MT Lui EH Yu W Shen YP Chen KW Chang HF Tu, Oral Oncol 2009 45 1032 1036 10.1016/j.oraloncology.2009.06.007 19666237
91. Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. CY Yen SY Liu CH Chen HF Tseng LY Chuang CH Yang YC Lin CH Wen WF Chiang CH Ho HC Chen ST Wang CW Lin HW Chang, J Oral Pathol Med 2008 37 271 277 10.1111/j.1600-0714.2007.00608. x 18410587
92. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. CF Chiu MH Tsai HC Tseng CL Wang FJ Tsai CC Lin DT Bau, Oral Oncol 2008 44 898 902 10.1016/j.oraloncology. 2007.11.007 18164646
93. Up-regulation of inflammatory signalings by areca nut extract and role of cyclooxy genase-2-1195G > a polymorphism reveal risk of oral cancer. SL Chiang PH Chen CH Lee AMS Ko KW Lee YC Lin PS Ho HP Tu DC Wu TY Shieh YC Ko, Cancer Res 2008 68 8489 8498 10.1158/0008-5472.CAN-08-0823 18922923
94. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. MP Tabor RH Brakenhoff HJ Ruijter-Schippers JA Kummer CR Leemans BJ Braakhuis, Clin Cancer Res 2004 10 11 3607 3613 10.1158/1078-0432.CCR-03-0632 15173066